Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease. Rabeprazole Study Group.

@article{Birbara2000RabeprazoleFT,
  title={Rabeprazole for the prevention of recurrent erosive or ulcerative gastro-oesophageal reflux disease. Rabeprazole Study Group.},
  author={Charles A Birbara and Jeffrey R Breiter and Carlos J. Vilalta y Perdomo and William A Hahne},
  journal={European journal of gastroenterology & hepatology},
  year={2000},
  volume={12 8},
  pages={889-97}
}
OBJECTIVES To evaluate the efficacy and tolerability of rabeprazole 10 mg and 20 mg versus placebo for the prevention of endoscopically demonstrable relapse in patients previously diagnosed with erosive or ulcerative gastro-oesophageal reflux disease (GORD) who had no oesophageal erosions or ulcerations at study entry. The study also assessed the effectiveness of rabeprazole in preventing GORD symptom recurrence and reductions in quality of life. DESIGN/METHODS The trial used a multicentre… CONTINUE READING
Highly Cited
This paper has 33 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…